Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.65% -0.20% 8.648M 1137.33
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
1.26% 55.00% -500389.0 Upgrade

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
General
Security Type Exchange-Traded Fund
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name J.P. Morgan Asset Management
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2018
2019
2020
2021
2022
2023
2024
YTD
--
--
--
--
--
--
-1.01%
12.36%
-8.71%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
20.21%
-1.47%
25.24%
18.96%
3.91%
-8.62%
9.64%
7.04%
18.27%
--
--
--
--
--
--
-4.30%
19.99%
--
--
--
-3.96%
-19.69%
5.70%
1.55%
20.44%
As of December 10, 2025.

Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.47%
Stock 98.44%
Bond 0.00%
Convertible 0.00%
Preferred 1.09%
Other 0.00%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
General
Security Type Exchange-Traded Fund
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name J.P. Morgan Asset Management
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders